Healthtech firm launches world’s first consumer epigenetic testing kit with £1.12m investment

Jan 10, 2019 · bdaily.co.uk

Fy38mvej06qkq0hcuv3qjjszmcp5tentqhuzlfaj

Healthtech company Chronomics has raised seven-figure seed funding and launched the world’s first consumer epigenetic testing kit.

The company has secured over £1.12m funding to date, including significant investment from venture capital firm Anthemis and follow-on backing from SOSV.

Other investors in Chronomics include angel Laurence Garrett, senior partner at Highland Europe.

Chronomics is seeking to revolutionise attitudes towards health management. It offers an epigenetic saliva test that profiles specific lifestyle and environmental indicators and provides accurate insights into an individual’s health, including their biological age and metabolic status.

Read Complete Article

RT @LDN_CDO: *Job Alert Klaxon* seeking a dynamic new director of a nascent & exciting new city unit, the London Office of Technology & Inn…

I’ll shortly be giving my regular update to @LondonAssembly, including on London’s support for Christchurch followi… https://t.co/gG7xDaMYll

Join us for a unique and prestigious opportunity to celebrate the start of #LTW 2019, in support of… https://t.co/npRlkqrYQw

Iran's Revolutionary Guards involvement in drilling for oil would signal a shift in the country's energy policy, ex… https://t.co/3xu4Xc8uv4

Using AI to improve sales https://t.co/1THiKsA47B by @TonyaHallRadio